Weijing Sun, MD, FACP The Sprint Professor of Medical Oncology Professor of Medical Onoclogy and Cancer Biology Chief, Division of Medical Oncology University of Kansas School of Medicine Associate Director, University of Kansas Cancer Center 2330 Shawnee Mission Pkwy, Suite 311/MS5032 Westwood, KS 66205 Phone: 913-574-0514; Fax: 913-588-3734 wsun2@kumc.edu Weijing Sun, MD is currently the Sprint Professor of Medical Oncology; Professor of Medical Onoclogy and Cancer Biology; the Chief of Medical Oncology Division, University of Kansas School of Medicine; and the Associate Director of University of Kansas Cancer Center for Clinic Research. He graduated from Shanghai Medical University (now mergied with Fudan University). He had his Internal Medicine residency training at Loyola University Medical Center, and Hematology-Oncology fellowship training at University of Pennsylvania. He served his assistant and associate professorship and had been the director of GI Medical Oncology at University of Pennsyvania until 2012. He then served his professorship, as the director of GI Medical Oncology and co-director of GI Cancer Research Exellency at the University of Pittsburgh until August, 2017 when he accepted the current position at the University of Kansas. He is a national and international expert in gastrointestinal cancers. He is focusing on the treatment and clinical research of GI malignancies, mainly on the development of new drugs and biologic/targeted oriented agents in treatment/therapy (including translational and immune research) of GI cancers with great experiences in the early phase clinical trial (phase I, II) designing, protocol development and conduction, and many of these have been published. He has served as a member of ECOG-ACRIN GI core committee; a member of NCI GI Cancer’s Steering Committee Hepatobiliary Task Force. He has served as PI for many investigate initiated studies and pharmaceutical companies’ trials. He has authored many publications including original clinical research articles, reviews, and invited editorial comments in a variety of peer-reviewed journals. He has also written chapters as a GI oncology expert for several medical textbooks including WebMD, Textbook of Gastroenterology. He is the editor-in-chief of the textbook of Multidisciplinary Therapy of GI Malignancies. He has had more than 170 publications. He is serving as a member of editorial boards or review committees for several professional journals. He serves as deputy editor-in-chief of Journal of Hematology & Oncology; associated editor of Journal of Practical Oncology, and Journal of Clinic Colorectal Cancer. He served ASCO (American Society of Clinical Oncology) scientific program committee (both colorectal and non-colorectal cancer subcommittees); and currently is serving as the head of colorectal cancer education committee of the 2020 ASCO annual meeting. He served the president of ISGIO (International Society of Gastrointestinal Oncology) 2021-2023. He served as the president and the board chair of CAHON (Chinses American Hematologist-Oncologist Network). He has been named as a ‘top doctor’ by US News and local magazines.